Literature DB >> 24519378

SurvMicro: assessment of miRNA-based prognostic signatures for cancer clinical outcomes by multivariate survival analysis.

Raul Aguirre-Gamboa1, Victor Trevino1.   

Abstract

UNLABELLED: MicroRNAs (miRNAs) play a key role in post-transcriptional regulation of mRNA levels. Their function in cancer has been studied by high-throughput methods generating valuable sources of public information. Thus, miRNA signatures predicting cancer clinical outcomes are emerging. An important step to propose miRNA-based biomarkers before clinical validation is their evaluation in independent cohorts. Although it can be carried out using public data, such task is time-consuming and requires a specialized analysis. Therefore, to aid and simplify the evaluation of prognostic miRNA signatures in cancer, we developed SurvMicro, a free and easy-to-use web tool that assesses miRNA signatures from publicly available miRNA profiles using multivariate survival analysis. SurvMicro is composed of a wide and updated database of >40 cohorts in different tissues and a web tool where survival analysis can be done in minutes. We presented evaluations to portray the straightforward functionality of SurvMicro in liver and lung cancer. To our knowledge, SurvMicro is the only bioinformatic tool that aids the evaluation of multivariate prognostic miRNA signatures in cancer.
AVAILABILITY AND IMPLEMENTATION: SurvMicro and its tutorial are freely available at http://bioinformatica.mty.itesm.mx/SurvMicro.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519378     DOI: 10.1093/bioinformatics/btu087

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  21 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

2.  miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.

Authors:  Ivan Bahena-Ocampo; Magali Espinosa; Gisela Ceballos-Cancino; Floria Lizarraga; Denise Campos-Arroyo; Angela Schwarz; Vilma Maldonado; Jorge Melendez-Zajgla; Patricia Garcia‐Lopez
Journal:  EMBO Rep       Date:  2016-04-09       Impact factor: 8.807

Review 3.  Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.

Authors:  Padacherri Vethil Jishnu; Pradyumna Jayaram; Vaibhav Shukla; Vinay Koshy Varghese; Deeksha Pandey; Krishna Sharan; Sanjiban Chakrabarty; Kapaettu Satyamoorthy; Shama Prasada Kabekkodu
Journal:  Clin Exp Metastasis       Date:  2019-12-07       Impact factor: 5.150

4.  An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

Authors:  Francesca Citron; Joshua Armenia; Giovanni Franchin; Jerry Polesel; Renato Talamini; Sara D'Andrea; Sandro Sulfaro; Carlo M Croce; William Klement; David Otasek; Chiara Pastrello; Tomas Tokar; Igor Jurisica; Deborah French; Riccardo Bomben; Emanuela Vaccher; Diego Serraino; Barbara Belletti; Andrea Vecchione; Luigi Barzan; Gustavo Baldassarre
Journal:  Clin Cancer Res       Date:  2017-02-07       Impact factor: 12.531

5.  Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.

Authors:  M Giulietti; G Occhipinti; G Principato; F Piva
Journal:  Cell Oncol (Dordr)       Date:  2017-02-15       Impact factor: 6.730

6.  Rs3842530 Polymorphism in MicroRNA-205 Host Gene in Lung and Breast Cancer Patients.

Authors:  Fan Zou; Jizhu Li; Xiaohua Jie; Xiong Peng; Ruiqi Fan; Mengmeng Wang; Jiangjie Wang; Zhuoqi Liu; Hua Li; Huan Deng; Xiaohong Yang; Daya Luo
Journal:  Med Sci Monit       Date:  2016-11-25

7.  YM500v3: a database for small RNA sequencing in human cancer research.

Authors:  I-Fang Chung; Shing-Jyh Chang; Chen-Yang Chen; Shu-Hsuan Liu; Chia-Yang Li; Chia-Hao Chan; Chuan-Chi Shih; Wei-Chung Cheng
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

8.  MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.

Authors:  Xiaochun Sun; Manhua Cui; Aichen Zhang; Lingling Tong; Kun Wang; Kai Li; Xue Wang; Ziqian Sun; Hongye Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-13

9.  Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.

Authors:  Peixin Dong; Kei Ihira; Ying Xiong; Hidemichi Watari; Sharon J B Hanley; Takahiro Yamada; Masayoshi Hosaka; Masataka Kudo; Junming Yue; Noriaki Sakuragi
Journal:  Oncotarget       Date:  2016-04-12

10.  High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer.

Authors:  Jongmin Sim; Hyein Ahn; Rehman Abdul; Hyunsung Kim; Ki-Jong Yi; Yu-Min Chung; Min Sung Chung; Seung Sam Paik; Young Soo Song; Kiseok Jang
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.